BlackRock, Inc. 13D and 13G filings for Madrigal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | BlackRock Inc. BLK | 1,212,562 6.100% | 225,990 (+22.91%) | Filing |
| 2023-02-01 4:54 pm Purchase | 2022-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | BlackRock Inc. BLK | 986,572 5.800% | 37,045 (+3.90%) | Filing |
| 2022-02-02 7:18 pm Purchase | 2021-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | BlackRock Inc. BLK | 949,527 5.600% | 5,109 (+0.54%) | Filing |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | BlackRock Inc. BLK | 944,418 6.100% | 944,418 (New Position) | Filing |